La Jolla Pharmaceutical Company (LJPC) To Provide Corporate Overview At The 9th Annual JMP Securities Healthcare Conference
6/19/2014 8:13:32 AM
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the “Company” or “La Jolla”), a leader in the development of therapeutics targeting significant unmet life-threatening diseases, today announced that George Tidmarsh, MD, Ph.D., President and Chief Executive Officer, will provide a corporate overview at the 9th Annual JMP Securities Healthcare Conference taking place June 24-25 in New York City.
Help employers find you! Check out all the jobs and post your resume.
comments powered by